Unlocking High-Sensitivity Structural Variant Detection and RNA Profiling for Cancer Research SCOTTS VALLEY, Calif. — Dovetail Genomics, a leading innovator in genomic solutions, today announces the availability of its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis, offering new capabilities for detecting structural variants and profiling RNA in oncology research. This service includes the detection of […]
Supports Company’s global commercial growth, driven by customer demand for integrated life sciences tools and solutions Cambridge, UK: Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions. […]
Discovery Life Sciences Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con in San Diego
Global Biospecimen Leader to Unveil Transformative Tool for Oncology Studies HUNTSVILLE, Ala. – Discovery Life Sciences (Discovery), a global leader in biospecimen solutions and specialty lab services, announced today that it will launch a new product to help advance oncology research, Tumoroid Cell Lines, OncoPro™ Medium-Derived, at Precision Med Tri-Con 2025, March 11-13 in San Diego, California. […]
Tolochenaz, Switzerland — Nanolive SA proudly announces its latest innovation, the Smart Mitochondrial AssayLIVE, the first label-free tool for real-time mitochondrial analysis. This AI-powered assay provides unprecedented accuracy in studying mitochondrial dynamics while preserving cell viability, setting a new standard for drug discovery, toxicology, and disease research. Figure 1: Nanolive’s holotomographic imaging and mitochondrial detection. […]
MARCO ISLAND, Fla. — Complete Genomics, a leading innovator in genomic sequencing, today unveiled its latest high-performance sequencing solutions at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. The newly introduced DNBSEQ-T1+* and DNBSEQ-E25 Flash* are designed to deliver speed, flexibility, and efficiency, empowering researchers with faster, high-quality genomic data. DNBSEQ-T1+: Mid-Throughput Sequencing with Industry-Leading Speed The […]
OPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking cancer testing applications MSK-ACCESS® powered with SOPHiA DDM™ and MSK-IMPACT® powered with SOPHiA DDM™. Thirty-seven prominent institutions, including top researchers […]
BOSTON — Volta Labs, a leading genomics applications company, today announced its four strategic focus areas for 2025 and the expansion of the Callisto App menu to include RNA library prep and single-cell prep, and multi-sequencer capabilities. Key strategic focus areas for Volta Labs in 2025 are: Launching DNA, RNA and single-cell preps for all labs […]
Accomplished marketing leader to drive strategic growth and customer-first initiatives NEWARK, Calif. — Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, today announced the appointment of Ashley Scholz as Vice President of Marketing. Ashley brings over 16 years of experience in marketing […]
The QuantumScale platform enables costs of less than 1 cent per cell with workflows across an unprecedented scale SAN DIEGO — Scale Biosciences (Scale Bio™), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell RNA kits, a set of next-generation single cell products which can capture and […]
Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now with expanded applications support and integration with leading ‘omics’ technologies Over 50% increase in output to 10 to 12 billion reads per wafer and pricing reduced by 20% to $0.24 per million reads, enabling the $80 genome Increased sensitivity […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
